Serotonin reuptake inhibitor formulations
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 13, 2004
Grant Date -
Oct 24, 2002
app pub date -
Feb 16, 2001
filing date -
Feb 16, 2001
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A process for preparing amorphous paroxetine hydrochloride or sertraline hydrochloride is provided, which comprises preparing a solution in which paroxetine hydrochloride or sertraline hydrochloride and a water-soluble polymer are dissolved in a co-solvent of a volatile organic solvent and water. Said solution is dried to obtain a composition comprising amorphous paroxetine hydrochloride or sertraline hydrochloride and the water-soluble matrix.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully